• Our concept and mission Studies using T-TAS have shown that consi-derable variability exists in both thrombogenicity and sensitivity to antithrombotic agents, which collectively result in large inter-individual variability with regard to thrombus formation among patients receiving antithrombotic therapy.
  • Why under blood flow condition? Blood flow is well recognized as a key factor that influences the thrombus formation process. Under arterial flow conditions, white thrombi comprising numerous activated platelets and fibrin fibers are formed, whereas red thrombi form under venous circulation predominantly consist of fibrin and red blood cells. The composition of thrombi affects the efficacy of antithrombotic agents.
  • Our microchip technologies We offer new partners of research collaboration as well as OEM production to create and produce an innovative assay system taking advantage of our microdevice technologies.
  • T-TAS 01 for clinical use (IVD)

    T-TAS 01 for clinical use (IVD)

    Total thrombus formation analysis system for clinical use. This system is conformed with IVD CE marking.
    T-TAS plus for research use only (RUO)

    T-TAS plus for research use only (RUO)

    Complete flow pressure and image analysis system equipped with a video microscope. A dedicated laptop containing all necessary software are included in the instrument package.
T-TAS products are available for research use only in the United States Copyright © 2019 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.